Literature DB >> 34971548

A Time-Series Feature-Based Recursive Classification Model to Optimize Treatment Strategies for Improving Outcomes and Resource Allocations of COVID-19 Patients.

Lin Wang, Zheng Yin, Mamta Puppala, Chika Ezeana, Kelvin Wong, Tiancheng He, Deepa Gotur, Stephen Wong.   

Abstract

This paper presents a novel Lasso Logistic Regression model based on feature-based time series data to determine disease severity and when to administer drugs or escalate intervention procedures in patients with coronavirus disease 2019 (COVID-19). Advanced features were extracted from highly enriched and time series vital sign data of hospitalized COVID-19 patients, including oxygen saturation readings, and with a combination of patient demographic and comorbidity information, as inputs into the dynamic feature-based classification model. Such dynamic combinations brought deep insights to guide clinical decision-making of complex COVID-19 cases, including prognosis prediction, timing of drug administration, admission to intensive care units, and application of intervention procedures like ventilation and intubation. The COVID-19 patient classification model was developed utilizing 900 hospitalized COVID-19 patients in a leading multi-hospital system in Texas, United States. By providing mortality prediction based on time-series physiologic data, demographics, and clinical records of individual COVID-19 patients, the dynamic feature-based classification model can be used to improve efficacy of the COVID-19 patient treatment, prioritize medical resources, and reduce casualties. The uniqueness of our model is that it is based on just the first 24 hours of vital sign data such that clinical interventions can be decided early and applied effectively. Such a strategy could be extended to prioritize resource allocations and drug treatment for futurepandemic events.

Entities:  

Mesh:

Year:  2022        PMID: 34971548      PMCID: PMC9243194          DOI: 10.1109/JBHI.2021.3139773

Source DB:  PubMed          Journal:  IEEE J Biomed Health Inform        ISSN: 2168-2194            Impact factor:   7.021


  22 in total

1.  Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.

Authors:  John H Beigel; Kay M Tomashek; Lori E Dodd
Journal:  N Engl J Med       Date:  2020-07-10       Impact factor: 91.245

Review 2.  Severe Covid-19.

Authors:  David A Berlin; Roy M Gulick; Fernando J Martinez
Journal:  N Engl J Med       Date:  2020-05-15       Impact factor: 91.245

3.  Predictive performance of international COVID-19 mortality forecasting models.

Authors:  Joseph Friedman; Patrick Liu; Christopher E Troeger; Austin Carter; Robert C Reiner; Ryan M Barber; James Collins; Stephen S Lim; David M Pigott; Theo Vos; Simon I Hay; Christopher J L Murray; Emmanuela Gakidou
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

4.  Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study.

Authors:  Davide Brinati; Andrea Campagner; Davide Ferrari; Massimo Locatelli; Giuseppe Banfi; Federico Cabitza
Journal:  J Med Syst       Date:  2020-07-01       Impact factor: 4.460

5.  Automated detection of COVID-19 cases using deep neural networks with X-ray images.

Authors:  Tulin Ozturk; Muhammed Talo; Eylul Azra Yildirim; Ulas Baran Baloglu; Ozal Yildirim; U Rajendra Acharya
Journal:  Comput Biol Med       Date:  2020-04-28       Impact factor: 4.589

6.  COVID-19 mortality risk assessment: An international multi-center study.

Authors:  Dimitris Bertsimas; Galit Lukin; Luca Mingardi; Omid Nohadani; Agni Orfanoudaki; Bartolomeo Stellato; Holly Wiberg; Sara Gonzalez-Garcia; Carlos Luis Parra-Calderón; Kenneth Robinson; Michelle Schneider; Barry Stein; Alberto Estirado; Lia A Beccara; Rosario Canino; Martina Dal Bello; Federica Pezzetti; Angelo Pan
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.240

7.  From predictions to prescriptions: A data-driven response to COVID-19.

Authors:  Dimitris Bertsimas; Leonard Boussioux; Ryan Cory-Wright; Arthur Delarue; Vassilis Digalakis; Alexandre Jacquillat; Driss Lahlou Kitane; Galit Lukin; Michael Li; Luca Mingardi; Omid Nohadani; Agni Orfanoudaki; Theodore Papalexopoulos; Ivan Paskov; Jean Pauphilet; Omar Skali Lami; Bartolomeo Stellato; Hamza Tazi Bouardi; Kimberly Villalobos Carballo; Holly Wiberg; Cynthia Zeng
Journal:  Health Care Manag Sci       Date:  2021-02-15

Review 8.  Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.

Authors:  James M Sanders; Marguerite L Monogue; Tomasz Z Jodlowski; James B Cutrell
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

9.  Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.

Authors:  Joshua Geleris; Yifei Sun; Jonathan Platt; Jason Zucker; Matthew Baldwin; George Hripcsak; Angelena Labella; Daniel K Manson; Christine Kubin; R Graham Barr; Magdalena E Sobieszczyk; Neil W Schluger
Journal:  N Engl J Med       Date:  2020-05-07       Impact factor: 91.245

10.  Clinical features of COVID-19 mortality: development and validation of a clinical prediction model.

Authors:  Arjun S Yadaw; Yan-Chak Li; Sonali Bose; Ravi Iyengar; Supinda Bunyavanich; Gaurav Pandey
Journal:  Lancet Digit Health       Date:  2020-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.